Ames, IA, United States of America

Milton J Allison

This inventor holds 6 USPTO granted patents. Top assignees: Ixion Biotechnology, Inc., The Milton J. Allison Revocable Trust, Oxthera Intellectual Property Ab. Active years: 2001-2020.


% Patents Active = 66.7

Average Co-Inventor Count = 2.0

ph-index = 4

Forward Citations = 79(Granted Patents)


Company Filing History:


Years Active: 2001-2020

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Milton J. Allison: Innovator in Oxalate-Related Disease Treatment

Introduction

Milton J. Allison is a notable inventor based in Ames, IA (US), recognized for his contributions to the field of medical treatments. He holds a total of 6 patents, focusing primarily on methods and compositions aimed at reducing oxalate levels in humans, animals, and plants.

Latest Patents

One of his latest patents is titled "Compositions and methods for treating or preventing oxalate-related disease." This invention comprises innovative methods and compositions designed to reduce oxalate in various organisms. Specifically, it provides techniques for delivering one or more oxalate-reducing enzymes to the intestinal tracts of both humans and animals. These methods can be effectively utilized in treating and preventing conditions related to oxalate.

Career Highlights

Throughout his career, Milton has worked with several organizations, including Ixion Biotechnology, Inc. and The Milton J. Allison Revocable Trust. His work has significantly impacted the understanding and treatment of oxalate-related diseases.

Collaborations

Milton has collaborated with various professionals in his field, including Harmeet Sidhu, enhancing the development of his innovative solutions.

Conclusion

Milton J. Allison's work in the treatment of oxalate-related diseases showcases his dedication to innovation and improving health outcomes. His patents reflect a commitment to advancing medical science and providing effective solutions for complex health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…